Related Articles
Survey of chemotherapy‑induced nausea and vomiting in patients with urothelial carcinoma
Timing of changing therapy from gemcitabine and cisplatin chemotherapy based on real‑world data of advanced urothelial carcinoma
Chemotherapy for urothelial carcinoma in renal transplantation patients: Initial results from a single center
Simple predictors for the completion of scheduled gemcitabine‑cisplatin regimens based on real‑world urothelial cancer data
The combination of paclitaxel and carboplatin as second-line chemotherapy can be a preferred regimen for patients with urothelial carcinoma after the failure of gemcitabine and cisplatin chemotherapy